TABLE 3. Rates of Incontinence and IAD During a Single Month From Each Observation Year.
Variable | 2016 | 2018 |
P Value (2016 vs 2018) |
2019 |
P Value (2016 vs 2019) |
2018 + 2019 |
P Value (2016 vs 2018 + 2019) |
---|---|---|---|---|---|---|---|
No. patients | 56 | 69 | 62 | 131 | |||
Age, mean (SD), y | 57.61 (15.4) | 57.87 (16.2) | .93a | 57.84 (16.5) | .94a | .92a | |
Gender, n (%) | .19b | .96b | .42b | ||||
Female | 25 (44.6%) | 39 (56.5%) | 28 (45.2%) | 67 (51.1%) | |||
Male | 31 (55.4%) | 30 (43.5%) | 34 (54.8%) | 64 (48.9%) | |||
Incontinence, n (%) | .0130c | .0050c | .0040c | ||||
Fecal | 10 (17.9%) | 3 (4.3%) | 5 (8.1%) | 8 (6.1%) | |||
Urinary | 0 | 6 (8.7%) | 5 (8.1%) | 11 (8.4%) | |||
Both | 3 (5.4%) | 6 (8.7%) | 13 (21.0%) | 19 (14.5%) | |||
Not incontinent | 43 (76.8%) | 54 (78.3%) | 39 (62.9%) | 93 (71.0%) | |||
IAD, n (%) | .12c | .08c | .06c | ||||
Yes | 9 (69.2%) | 6 (40.0%) | 9 (39.1%) | 15 (39.5%) | |||
No | 4 (30.8%) | 9 (60.0%) | 14 (60.9%) | 23 (60.5%) |
Abbreviation: IAD, incontinence-associated dermatitis.
aAnalysis based on the t test.
bAnalysis using the χ2 test.
cAnalysis using Fisher's exact test.